Clinical efficacy of an OT pathway in the treatment of DCX injection
Research type
Research Study
Full title
A study of the clinical efficacy of an occupational therapy pathway in the treatment of Dupuytren's disease with Xiapex injection: evaluating functional improvement post manipulation and activities of daily living
IRAS ID
230809
Contact name
Yvonne Roberts
Contact email
Sponsor organisation
BCUHB
Duration of Study in the UK
1 years, 8 months, 15 days
Research summary
We are aiming to analyse the clinical effectiveness of the treatment and implementation of the occupational therapy pathway within the management of Xiapex injection for the treatment of Dupuytren’s disease.
We will be specifically focusing upon the functional improvement of the patient compared with pre injection and manipulation via the use of baseline measurements and patient reported outcome measures(PROMs).
For the purposes of this study we have altered the delivery of the occupational therapy pathway to ensure that we are able to gain pre and post injection/ manipulation data. These amendments include;
• Measurement of the affected finger/ thumb pre Xiapex injection and PROMs questionnaire• Once the patient has reached an optimal level of function the OT will ask further PROMs questions
• Follow up appointment at six and twelve months, for further measurements and PROMs
The purpose of this study is to ensure that we are delivering the best possible service within occupational therapy for those who are affected by Dupuytren's disease who are receiving the Xiapex injection pathway for their treatment. We also aim to assess the longer term benefits of the procedure/ pathway. For the data collection we will use the first fifty adult participants who are able to engage and complete the twelve month pathway.
REC name
East of England - Essex Research Ethics Committee
REC reference
17/EE/0507
Date of REC Opinion
16 May 2018
REC opinion
Further Information Favourable Opinion